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Achillea species are widely used for diarrhea, abdominal pain, stomachache and healing of wounds in folk medicine. To evaluate
the wound healing activity of the plant, extracts were prepared with diﬀerent solvents; hexane, chloroform, ethyl acetate and
methanol, respectively from the roots of Achillea biebersteinii. Linear incision by using tensiometer and circular excision wound
models were employed on mice and rats. The wound healing eﬀect was comparatively evaluated with the standard skin ointment
Madecassol. The n-hexane extract treated groups of animals showed 84.2% contraction, which was close to contraction value of
the reference drug Madecassol (100%). On the other hand the same extract on incision wound model demonstrated a signiﬁcant
increase (40.1%) in wound tensile strength as compared to other groups. The results of histoptologicalexamination supported the
outcome of linear incision and circular excision wound models as well. The experimental data demonstrated that A. biebersteinii
displayed remarkable wound healing activity.
1.Introduction
The genus Achillea (Asteraceae), named after the mytholog-
ical Greek warrior Achilles, who used Achillea species for
healing wounded-soldiers during the Trojan War [1]. The
genus Achillea comprises of ∼85 species, most of which
are endemic to Europe and the Middle East. Turkish ﬂora
possesses 42 Achillea species and 23 of them are endemic [2].
These species have some interesting properties and are used
in cosmetics, fragrances and agriculture, for example, plant
protection [3]. Some Achillea species have been known to
be ethnopharmacologically used in folk remedies for various
purposessuchashemorrhoid and woundhealing [4].Herbal
teas prepared from some Achillea species are very often used
in folk medicine as diuretic, for abdominal pain, against
diarrhea, ﬂatulence and emmenagog, moreover for wound
healing purposses, in Turkey [5–7].
Achillea biebersteinii is locally named Sarıc ¸ic ¸ek in Turk-
ish, and other species widely used as a folk remedy to treat
abdominal pain, wounds and stomachache as well [8, 9].
A. biebersteinii Afan. [Asteraceae, Section: Filipendulinae
(D.C.) Boiss] (syn. A. micrantha) is a perennial herb, villose,
stems erect, simple or branched from the base; 30–60cm
high; leaves up to 10cm, oblong-lanceolate in outline, pin-
natisect into numerous narrow segments, segments divided
into minute linear-lanceolate mucronate lobes; the heads
are radiate, in large dense compound corymbs; involucre 4-
5mm, oblong-ovoid; ﬂowering period, April-May.
Several biological activity studies have been performed
on various Achillea species, including antibacterial, antiox-
idant, anti-inﬂammatory and antispasmodic activities [10–
13].
The aim of the present study was to investigate thein vivo
woundhealing activityofA.biebersteinii inordertoelucidate
traditional use of this plant from the scientiﬁc point of
view. The hexane, chloroform, ethyl acetate and methanolic
extracts prepared from the aerial parts of the mentioned
plant were tested in mice and rats for wound healing activity
using in vivo circular excision and linear incision wound
models.2 Evidence-Based Complementary and Alternative Medicine
2.Materialsand Methods
2.1. Plant Material. Achillea biebersteinii Afan. aerial parts
were collected from Beynam forest, Ankara, Turkey, in
May 2007 and was identiﬁed by Prof. Dr M. Vural from
the Department of Botany, Faculty of Art and Science,
Gazi University. A voucher specimen was deposited in the
Herbarium of Faculty of Pharmacy, Gazi University (GUE-
2602).
2.2. Extraction. Following dissection of the aerial parts of
A. biebersteinii Afan., they were shade dried. Each 30g
aerial parts was submitted to successive solvent extractions
seperatelly with n-hexane, chloroform, ethyl acetate and
methanol at room temperature for a day (500ml each
solvent). This was repeated in two trials. After ﬁltration, the
extracts were evaporated at 40◦C (Buchi, Switzerland) to
dryness in vacuo. Yields of each extracts were 7.9% for n-
hexane, 4.8% for diethyl ether, 1.3% for ethyl acetate and
15.3% for methanol.
2.3. GC-MS Analysis of the n-Hexane Fraction. Chromato-
graphic analysis was carried out on Agilent 6890N Network
GC system combined with Agilent 5973 Network Mass
Selective Detector (GC-MS). The capillary column used was
an HP 5 MS Column (30m × 0.25mm × 0.25μm). Helium
w a su s e da sc a r r i e rg a sa taﬂ o wr a t eo f1m l / m i nw i t h1μl
injection volume. Samples were analyzed with the column
held initially 60◦C for 1 min after injection with 1 min hold
time, then increased to 180◦Cw i t h3 ◦C/min heating ramp
a n dk e p ta t1 8 0 ◦C for 20 min. The injection was performed
in splitless mode. Detector and injector temperatures were
280◦C and 250◦C, respectively. Run time was 60 min. MS
scan range was (m/z): 35–500 atomic mass units (AMU)
under electron impact (EI) ionization (70 eV).
2.4. Animals. Male, Sprague-Dawley rats (160–180g body
weight) and Swiss albino mice (20–25g body weight) were
purchased from the animal breeding laboratories of Reﬁk
Saydam Central Institute of Health (Ankara, Turkey).
The animals left for 3 days at room conditions for
acclimatization. They were maintained on standard pellet
diet and water ad libitum throughout the experiment. A
minimum of six animals were used in each group, otherwise
described in procedure. The study was permitted by the
Institutional Animal Ethics Committee (Gazi University
Ethical Council Project Number: G.U.ET-08.037) and was
performed according to the international rules considering
the animal experiments and biodiversity right.
2.5. Wound Healing Activity. Incision and excision wound
models were used to evaluate the wound healing activity.
For the in vivo wound models, samples were prepared in the
ointment consists of propylene glycol:liquid paraﬃn( 6:1 )
and applied topically onto the test animals Extracts were
prepared as 1% in the ointment, and 0.5mg of it applied
on the wound sides immediately after wound was created
artiﬁcially.
The vehicle group of animals was treated with the
ointment only. The negative control group of animals was
not treated with a material. Commercial Madecassol, 0.5g
(Bayer) was applied as a reference drug.
2.6. Linear Incision Wound Model. All the animals were
anaesthetized with 0.15cc Ketalar and the back hair of
the rats were shaved by using a shaving machine. Five
centimeters long, two linear-paravertebral incisions were
made with a sterile blade through the full thickness of the
skin at the distance of 1.5cm from the midline of each side
of the vertebral column [14]. The wounds were closed with
three surgical interrupted sutures of 1cm apart. The animals
were divided into four groups. The extracts, the reference
material (Madecassol) and the vehicle were topically applied
once in a day through 9 days. The fourth group, negative
control group of animals, was not treated with a material.
All the sutures were removed on the 9th post wound day.
On day 10 all the animals were killed with ether anesthesia.
One linear-paravertebral incised skin was measured using
tensiometer (Zwick/Roell Z0.5, Germany) for its tensile
strength, theotherincised skinwassent forhistopathological
examination [15, 16].
2.7. Excision Wound Model. This model was used to monitor
wound contraction and wound closure time. Each group
of animals (six-animal each) was anaesthetized by 0.01cc
Ketalar. The backhairs of themicewere depilatedbyshaving.
The circular wound was created on the dorsal interscapular
region of each animal by excising the skin with a 5 mm
biopsy punch; wounds were left open [17]. The extracts,
the reference material (Madecassol Bayer) and the vehicle
ointment were administered once a day till the wound was
completely healed. The progressive changes in wound area
were monitored by a camera (Fuji, S20 Pro, Japan) every
otherday.Lateron,woundareaevaluatedbyusing AutoCAD
program. Woundcontraction wascalculatedaspercentageof
the reduction in wounded area. A specimen sample of tissue
was isolated from the healed skin of each group of mice for
the histopathological examination [18].
2.8. Histological Study. Sample tissues were ﬁxed in 10%
formalin and were embedded in paraﬃn wax. Serial sections
(5μm thickness) of paraﬃn embedded tissues were cut. The
tissues were stained by haematoxylin and eosin, which were
examined by light microscope (Olympus BX51). Ulceration,
necrosis and epithelisation were evaluated in the skin tissues.
A l s oc o n g e s t i o n ,e d e m a ,P N L ,m o n o n u c l e a rc e l l s ,ﬁ b r o b l a s t s
and vascularisation were qualitatively evaluated as −,+ ,+ +
and +++.
2.9. Statistical Analysis of the Data. The data on percentage
wound healing was statistically analyzed using one-way
analysis of variance (ANOVA). The values of P ≤ .001 were
considered statistically signiﬁcant.
Mann-Whitney U, Kruskal-Wallis and chi-squared tests
were used for the statistical analysis of the histopathological
data.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Eﬀects of the extracts from A. biebersteinii on circular
excision wound model.
3.Results
3.1. Excision and Incision Wound Models. In this study,
an enquiry on wound healing activity of the n-hexane,
chloroform, ethyl acetate and methanol extracts prepared
from aerial parts of A. biebersteinii, which has been used in
the treatment of wounds was carried out on mice and on
rats by excision and linear incision wound models to verify
the claimed traditional use of the plant on a scientiﬁc base.
More to the point, histopathologic examination of the same
extracts were also assessed.
The measurements of the progress of wound healing
induced by the extracts, reference drug, negative control and
vehicle groups in the excision wound model are shown in
Figure 1.T h en-hexane extract treated groups of animals
showed 61.7% (P < . 0 1 )c o n t r a c t i o no nt h ew o u n d so n
day eight. This extract demonstrated 84.2% (P < .001)
contraction on day twelfth, which was close to contraction
value of the reference drug Madecassol
￿ (100%). On the
given days, other extracts showed no signiﬁcant results.
The results of the measurements of tensile strength
are shown in Figure 2. Tensile strength of the animals
treatedwithn-hexane extractdemonstratedthehighestvalue
(40.1%, P < .001) on day 10. Topical application of the n-
hexane extract on incision wound model demonstrated a
signiﬁcant increase in wound tensile strength as compared
to other groups.
3.2. Histological Study. Histopatological examinations of the
negative control exhibited wide area of ulceration containing
ﬁbrinous exudate and inﬂammatory cells, mild degree
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Figure 2: Eﬀects of the extracts from A. biebersteinii on linear
incision wound model.
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Figure 3:Microscopicview ofthe sectionofnegative controlgroup
(untreated) 10 days old wound tissue. (a) area of ulceration; (b)
mixed type inﬂammatory cells; (c) edema and (d) congested vessel.
inﬂammation and mixed type inﬂammatory cells in dermis,
slightly increased vascularization with congestion, which
alltogether show that the healing was not completed on
the wounded area (Figure 3). When the n-hexane extract
treated group was histopathologically analyzed, establish-
ment of collagen ﬁbers, ﬁbroblasts and mature hair follicles
were obviously seen on the representing picture (Figure 4).
Moreover, no scar tissue on the dermis in n-hexane treated
group exhibits that the healing was almost completed. In a
similar way, group treated with Madecassol showed mature
epidermis with keratinization and mature hair follicles,
ﬁbroblasts in dermis that are the proof of completion of
healing (Figure 5). Histological observation suggested that
the phytochemical content of the n-hexan extract might
be responsible for collagen formation at the proliferative
state, which is contributed by increased ﬁbroblats content
(Figure 6).4 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Microscopic view of the section of 10 days old wound
tissue treated with n-hexane extract. (a) hair follicle; (b) ﬁbroblast;
(c) collagen ﬁbres and (d) blood vessel.
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Figure 5: Microscopic view of the section of 10 days old wound
tissue treated with Reference material Madecassol
￿ (a) intact
epidermis; (b) keratinization; (c) collagen ﬁbers and (d) hair
follicle.
4.Discussion
Overall the histopathological examinations showed that
healing process of the wounded tissue in n-hexane treated
group was comparably close to the reference drug treated
group, whereas no healing was observed in negative control
group (untreated). Granulation tissue primarily contains
ﬁbroblasts, collagen ﬁbres, very less edema and newly gen-
erated blood vessels, which were also observed in n-hexane
extract treated group of animals. This histopathological
observationprovidedadditionalevidencefortheexperimen-
tal wound healing studies based on the contraction value
of wound areas and the measurement of tensile strength
(Figures 3–5).
In the present study, the n-hexane extract of A. bieber-
steinii aerial parts was found to be remarkably active on
in vivo wound models, whereas the other extracts were
n o ta sa c t i v ea st h en-hexane extract. This prompted us
to analyze and identify chemical composition of the n-
hexane extract directly by capillary GC-MS. Analysis of
the n-hexane fraction revealed that the major compounds
were determined as sesquiterpenoid β-Eudesmol, piperitone,
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Figure 6: The hypothetical diagram demonstrating the possible
eﬀect of the extract of A. biebersteinii in wound healing activity.
camphor, borneol, α-terpinene, 1,8-cineole, although their
amounts were 19.1%, 9.2%, 4.2%, 3.3%, 2.9% and 2.5%
respectively representing 100% of the extract (Table 1).
Achillea species have been so far reported to contain
diterpenes, sesquiterpenes, ﬂavonoids, lignans, essential oil
and rarely triterpenes [19–26]. For instance, A. vermic-
ularis was shown to have guaianolide- and germacrene-
type sesquiterpenes as well as ﬂavonoids, whereas A. setacea
was reported to contain sesquiterpenes, essential oils and
ﬂavonoids [20, 21, 27]. In addition to extracts, essential
oils of the Achillea species were also analysed. The oil of A.
pachycephala was found to contain 1,8-cineole and camphor
as the major constituents, whereas 1,8-cineole and artemisia
ketone were major in A. oxyodonta. On the other hand
A. biebersteinii was rich in camphor and borneol followed
by 1,8-cineole. It was stated that all the oils were rich in
oxygenated monoterpenes [28]. Non-volatile components
of A. biebersteinii aﬀorded in addition to β-sitosterol,
stigmasterol two sesquiterpene lactones, germacranolide
[29]. Essential oil of A. millefolium consists of a number
of monoterpenes such as α-pinene, β-pinene, 1,8-cineole,
camphor and borneol in addition to some sesquiterpene
lactones of germacrene-derivatives [25]. Major component
in the essential oils of both A. setacea and A. teretifolia
was elucidated to be 1,8-cineole [27]w h e r e a sα-pinene, 1,8-
cineole and camphor as well as germacreneD and bisabolene
as the major constituents of ten other Achillea species
(A. biserrata, A. clypeotala, A. crithmifolia, A. ﬁlipendula,
A. macrophylla, A. pannonica, A. pyrenaica, A. sibirica, A.
taygetea and A. tenuifolia)[ 23].
Various biological activity studies were also completed
on Achillea species. The antimicrobial and antioxidant
activities of the essential oil and the methanolic extract of
A. biebersteinii were studied in vitro by Baris et al. [30].
The essential oil showed antimicrobial activity against 8
bacteria sp., 14 fungi sp. and the C. albicans,w h e r e a st h e
methanolic extract remained inactive. GC-MS analysis of the
essential oil resulted in the identiﬁcation of 64 components
representing 92.24% of the oil, piperitone, camphor and
1,8-cineole (eucalyptol) as being major constituents [30]. In
another study, antimicrobial activity tests carried out with
the fractions of the oil revealed that the major activity wasEvidence-Based Complementary and Alternative Medicine 5
Table 1: GC-MS analysis results of n-hexane fraction.
Components identiﬁed Retention times
(Rt,m i n )
Composition (%)
n-hexane fr.
1,8-Cineole 7.762 2.531
Linalool 10.232 0.167
Camphor 11.909 4.244
Borneol 12.783 3.335
Terpinen-4-ol 13.269 0.439
α-Terpinene 13.836 2.989
Piperitone 16.487 9.190
Bicyclo
[2,2,1]heptane-2,5-dione 16.808 0.305
1,7-Octadiene-3,6-diol 17.370 0.399
Thymol 18.227 0.240
Tridecane 18.482 0.387
4-Hydroxy-2-
methylacetophenone 18.622 0.286
2,4-Heptadien-1-ol 20.412 0.262
(E)-˙ Isoeugenol 20.824 0.282
α-Amorphene 21.131 0.641
α-Copaene 21.531 1.262
Decanoic acid 21.673 0.981
Tetradecane 22.655 0.640
Cadinene 27.108 0.496
2-(4H)-Benzofuranone 27.596 0.785
2-Cyclopenten-1one 29.254 0.388
Caryophyllene oxide 29.719 3.123
Hexadecane 30.542 4.220
Aromadendrene 31.482 0.480
δ-Selinene 31.592 0.504
Caryophylla-4(14),
8(15)-dien-5-beta-ol 31.737 1.162
β-Eudesmol 32.293 19.111
Alloaromadendrene 32.549 0.756
Vulgarol B 33.565 0.506
3-Buten-2-one 33.695 0.297
Cyclodecane 34.011 0.633
(–)-Loliolide 36.380 0.580
Cis,cis-7,10,-
Hexadecadienal 37.195 0.416
Octadecane 37.746 1.110
Oxirane 38.274 0.666
Cyclohexanone 39.057 0.381
Cyclohexadecanolide 39.222 5.544
Benzylsalicylate 39.852 1.137
Phthalic acid 39.982 2.590
Tetradecene 40.402 1.302
1-Methyldodecylbenzene 41.282 0.463
Hexadecanoic acid 43.632 1.338
Cyclohexane 44.606 0.959
Table 1: Continued.
Components identiﬁed Retention times
(Rt,m i n )
Composition (%)
n-hexane fr.
1,15-Hexadecadiene 45.874 0.480
Oleic acid 46.797 0.536
n-Hexadecanol 49.275 0.991
Heneicosane 50.396 0.887
Phytol 51.125 2.941
Methyl linoleate 52.309 3.028
Others — 13.61
Total 100
observedin those contain 1,8-cineoleand camphor, followed
by borneol and piperitone [31].
When a wound occurs and is exposed to external
environment, it is more prone to attack by microbes, which
invade through the skin and delay the natural wound
healing process. Reactive oxygen species (ROS), are vital
part of healing and serve as cellular messengers that drive
numerous aspects of molecular and cell biology. ROS can
trigger the various beneﬁcial pathways of wound healing,
for example, at micromolar concentrations of hydrogen
peroxide can promote vascular endothelial growth factor
(VEGF) expression in keratinocytes [32, 33]. During the
inﬂammation phase ofhealing neutrophilsand macrophages
are attracted into the injured tissue by various chemotactic
factors. They locate, identify, phagocytize, kill and digest
microorganisms and eliminate wound debris through their
characteristic “respiratory burst” activity and phagocytosis
[34]. At high concentrations, ROS can induce severe tissue
damage and even lead to neoplastic transformation, which
further impede the healing process by causing damage to
cellular membranes, DNA, proteins and lipids as well [35].
Hence, if a compound or a plant extract having antioxidant
potentials and antimicrobial activity additionally, it can be
a good therapeutic agent for accelerating the wound-healing
process.
Several preparations containing A. millefolium extract
was quite successfully healed the wounds and scars. The
liniment containing hiperisin oil and A. millefolium extract
patented by Motogna accelerates the healing of wounds and
gives esthetic scars. Since the liniment is applied as a spray it
is easily applied and painless [36]. The activiy most probably
comes from the synergistic eﬀect of compounds present in
the extract and also additive eﬀect of hiperisin.
According to ethnopharmacological studies botanical
remedies provide two advantages over single-compound
drugs: primary active compounds in plants are synergized
by secondary compounds and secondary compounds ease
the side eﬀects caused by primary active compounds. The
course of searching an ethnopharmacologically active plant
extractdowntoasingle activeprincipalmayresultinadefeat
of biological activity for a number of reasons, for instance,
a special compound might be unstable during extraction,
fractionation or in the puriﬁed form, or, the fundamental
basis forethnopharmacologydoesnot alwaysexist in a single6 Evidence-Based Complementary and Alternative Medicine
active compound but rather is a result of the interaction
of more than one active compounds found in the extract
[37]. Moreover, that single compound might potentiate the
activityandthatsinglecompoundbecometoxiccomparedto
whole plant extract [38]. Thus, thelikelihood that more than
one compound present in a plant extract could contribute to
a net pharmacological response of the extract.
5.Conclusion
According to results reported here n-hexane extract of
Achillea biebersteinii was found to have better activity on
the wound healing experimental models compared to the
other extracts. Even though the analysis of the n-hexane
extract revealed that the major compounds were determined
as sesquiterpenoid β-Eudesmol, piperitone, additional com-
pounds, such as camphor, borneol, α-terpinene and 1,8-
cineole were also determined. This unveils that the extract
was not dominated by a single compound, whereas the
extract contains various eﬀective compounds in diﬀerent
quantities. This may suggest that β-Eudesmol and piperitone
solely could not be reason for the activity but mostly
synergistic interaction with the rest of the ingredients might
bepromotingthewoundhealingactivity.Thisstudyprovides
scientiﬁc evidence to the ethnomedicinal futures of A.
biebersteinii.
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